Huntington’s Disease Clinical Trials Corner: April 2020

In this edition of the Huntington’s Disease Clinical Trials Corner we expand on the UniQure AMT-130 and on the Neurocrine Biosciences KINECT-HD trials, and list all currently registered and ongoing clinical trials in Huntington’s disease.

Saved in:
Bibliographic Details
Published inJournal of Huntington's disease Vol. 9; no. 2; pp. 185 - 197
Main Authors Rodrigues, Filipe B., Wild, Edward J.
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.01.2020
Sage Publications Ltd
Subjects
Clinical trials
Clinical Trials as Topic
Genetic Therapy
Humans
Huntington Disease - drug therapy
Huntington Disease - therapy
Huntington's disease
Huntingtons disease
Randomized Controlled Trials as Topic
Tetrabenazine - analogs & derivatives
Tetrabenazine - pharmacology
Valine - analogs & derivatives
Valine - pharmacology
Vesicular Monoamine Transport Proteins - antagonists & inhibitors
clinical trials
Huntington disease
Online AccessGet full text

Cover

More Information
Summary:In this edition of the Huntington’s Disease Clinical Trials Corner we expand on the UniQure AMT-130 and on the Neurocrine Biosciences KINECT-HD trials, and list all currently registered and ongoing clinical trials in Huntington’s disease.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:1879-6397
1879-6397
1879-6400
DOI:10.3233/JHD-200002